Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 1/20 | 1.00 |
| ▸ | F2 | P00734 | 1/20 | 0.71 |
| ▸ | F10 | P00742 | 1/20 | 0.71 |
| ▸ | F12 | P00748 | 1/20 | 0.71 |
| ▸ | F7 | P08709 | 1/20 | 0.71 |
| ▸ | F3 | P13726 | 1/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | NQO2 | P16083 | 7/20 | 0.70 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.65 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.65 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.65 |
| ▸ | C1S | P09871 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TOP1 | P11387 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | CASP1 | P29466 | 1/20 | 0.56 |
| ▸ | CASP7 | P55210 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6029673 | 0.98 | WDR5 (0.95) | WDR5F2F10F12F7 | |
| Biphenyl SCHEMBL28438673 | 0.92 | WDR5 (0.86) | WDR5F2F10F12F7 | |
| SCHEMBL26081559 | 0.91 | WDR5 (0.83) | WDR5F2F10F12F7 | |
| Biphenyl SCHEMBL2456187 | 0.90 | BLM (0.85) | WDR5F2F10F12F7 | |
| SCHEMBL394218 | 0.89 | WDR5 (0.80) | WDR5F2F10F12F7 | |
| SCHEMBL8973288 | 0.89 | WDR5 (0.80) | WDR5F2F10F12F7 | |
| Benzamidine SCHEMBL23067876 | 0.84 | F2 (1.00) | WDR5F2F10F12F7 | |
| SCHEMBL18557033 | 0.84 | F2 (1.00) | WDR5F2F10F12F7 | |
| Benzamidine SCHEMBL27781057 | 0.84 | F2 (1.00) | WDR5F2F10F12F7 | |
| Benzamidine SCHEMBL9207 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117926289-A | Method for electrochemically synthesizing N-sulfoamidine derivatives under mild condition | 湘潭大学 | 2024-04-26 | — | — | CN | claimed |
| CN-121717766-A | Preparation method of ultraviolet absorber UV-1600 intermediate | 安徽英特美科技有限公司 | 2026-03-24 | — | — | CN | disclosed |
| US-20240150506-A1 | CURING AGENTS FOR FLUOROELASTOMERS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2024-05-09 | — | — | US | disclosed |
| CN-117926289-A | Method for electrochemically synthesizing N-sulfoamidine derivatives under mild condition | 湘潭大学 | 2024-04-26 | — | — | CN | disclosed |
| WO-2024086246-A2 | 2-SUBSTITUTED 3,4 A, 5, 7, 8, 8 A-HEXAHYDRO-4H-THIOP YRANO [4,3- DJPYRIMIDIN-4-ONES FOR WOUND TREATMENT | Eluciderm Inc. (US) | 2024-04-25 | — | — | WO | disclosed |
| CN-117529520-A | Fluoroelastomer compositions containing curative | 杜邦特种产品美国有限公司 | 2024-02-06 | — | — | CN | disclosed |
| EP-4305096-A1 | FLUOROELASTOMERS COMPOSITION COMPRISING CURING AGENTS | Dupont Specialty Products USA, LLC (US) | 2024-01-17 | — | — | EP | disclosed |
| WO-2022192006-A1 | FLUOROELASTOMERS COMPOSITION COMPRISING CURING AGENTS | DUPONT POLYMERS, INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| US-20220216422-A1 | Electroluminescent Device | UDC IRELAND LTD (IE) | 2022-07-07 | — | — | US | disclosed |
| CN-110670090-B | Method for synthesizing isoquinolone compound based on electrochemistry | 广西师范大学 | 2021-06-29 | — | — | CN | disclosed |
| US-8012602-B2 | Blue emitting, durable, organoelectroluminescent layers containing pyrimidine moieties; full color displays; light emission efficiency and brightness | BASF SE (DE) | 2011-09-06 | — | — | US | disclosed |
| US-8012602-B2 | Blue emitting, durable, organoelectroluminescent layers containing pyrimidine moieties; full color displays; light emission efficiency and brightness | BASF SE (DE) | 2011-09-06 | — | — | US | disclosed |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | SCHAEFER THOMAS | 2010-09-23 | — | — | US | disclosed |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | SCHAEFER THOMAS | 2010-09-23 | — | — | US | disclosed |
| EP-1213283-B1 | Biphenyl-substituted triazines as light stabilisers | CIBA HOLDING INC (CH) | 2009-04-29 | — | — | EP | disclosed |
| EP-1556360-B1 | ELECTROLUMINESCENT DEVICE | CIBA SC HOLDING AG (CH) | 2008-01-23 | — | — | EP | disclosed |
| EP-1332151-A1 | PYRANOSIDE DERIVATIVES | Boehringer Ingelheim Pharma KG (DE) | 2003-08-06 | — | — | EP | disclosed |
| US-6489359-B2 | BENZAMIDINE DERIVATIVES CONTAINING A SULFATE GROUP; USE AS LEUKOTRIENE B4 (LTB4) ANTAGONISTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-12-03 | — | — | US | disclosed |
| US-20020161043-A1 | Sulphoxybenzamides | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-10-31 | — | — | US | disclosed |
| WO-2002034761-A1 | PYRANOSIDE DERIVATIVES | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220216422-A1 | Electroluminescent Device | PNPO, ODC1, AXL | WDR5 1405/4885F2 1652/4885F10 3128/4885 |
| US-20020161043-A1 | Sulphoxybenzamides | SULT2A1, SULT1A1, SDHB | WDR5 3796/4885F2 1471/4885F10 3154/4885 |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | PNPO, ODC1, AXL | WDR5 1405/4885F2 1652/4885F10 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.